# Post-Market Evaluation of HEMOBLAST™ Bellows in Laparoscopic Abdominal, Gynecological, and Urological Surgery

> **NCT03873181** · — · COMPLETED · sponsor: **Biom'Up France SAS** · enrollment: 102 (actual)

## Conditions studied

- Hemostasis

## Interventions

- **DEVICE:** HEMOBLAST™ Bellows

## Key facts

- **NCT ID:** NCT03873181
- **Lead sponsor:** Biom'Up France SAS
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-16
- **Primary completion:** 2020-08-26
- **Final completion:** 2020-08-26
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2020-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03873181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03873181, "Post-Market Evaluation of HEMOBLAST™ Bellows in Laparoscopic Abdominal, Gynecological, and Urological Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03873181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*